switching from tirzepatide to retatrutide dosage and What You Should Know Before Making the Change Switching between tirzepatide and retatrutide

2016 Oct 1;176(10):1464-1473. TCB TCBJSASJSAPSAcute Care Surgery TCB2 TCBTVCM 2026/6/16 STV2026/6/16TCB 2026/6/16 2026/6/15UHBTCB 2026/4/30 2026/4/30FNN Live News daysTCB TCB

Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023

Funding Open access funding provided by Universit Paris-Saclay

Two pharmacoepidemiological analyses using electronic health records have reported that use of GLP-1R agonists is associated with lower rates of opioid overdose